Central Nervous System Effects [see Warnings and Precautions (5.2)] |
Grade 1 | Continue at the same dose or withhold the dose until recovery to baseline. Resume LORBRENA at the same dose or at a reduced dose. |
Grade 2 OR Grade 3 | Withhold dose until Grade 0 or 1. Resume LORBRENA at a reduced dose. |
Grade 4 | Permanently discontinue LORBRENA. |
Hyperlipidemia [see Warnings and Precautions (5.3)] |
Grade 4 hypercholesterolemia OR Grade 4 hypertriglyceridemia | Withhold LORBRENA until recovery of hypercholesterolemia and/or hypertriglyceridemia to less than or equal to Grade 2. Resume LORBRENA at the same dose. If severe hypercholesterolemia and/or hypertriglyceridemia recurs, resume LORBRENA at a reduced dose. |
Atrioventricular (AV) Block [see Warnings and Precautions (5.4)] |
Second-degree AV block | Withhold LORBRENA until PR interval is less than 200 ms. Resume LORBRENA at a reduced dose. |
First occurrence of complete AV block | Withhold LORBRENA until - 1.
- pacemaker placed OR
- 2.
- PR interval less than 200 ms.
If a pacemaker is placed, resume LORBRENA at the same dose. If no pacemaker is placed, resume LORBRENA at a reduced dose. |
Recurrent complete AV block | Place pacemaker or permanently discontinue LORBRENA. |
Interstitial Lung Disease (ILD)/Pneumonitis [see Warnings and Precautions (5.5)] |
Any Grade treatment–related ILD/Pneumonitis | Permanently discontinue LORBRENA. |
Hypertension [see Warnings and Precautions (5.6)] |
Grade 3 (SBP greater than or equal to 160 mmHg or DBP greater than or equal to 100 mmHg; medical intervention indicated; more than one antihypertensive drug, or more intensive therapy than previously used indicated) | Withhold LORBRENA until hypertension has recovered to Grade 1 or less (SBP less than 140 mmHg and DBP less than 90 mmHg), then resume LORBRENA at the same dose. If Grade 3 hypertension recurs, withhold LORBRENA until recovery to Grade 1 or less, and resume at a reduced dose. If adequate hypertension control cannot be achieved with optimal medical management, permanently discontinue LORBRENA. |
Grade 4 (life-threatening consequences, urgent intervention indicated) | Withhold LORBRENA until recovery to Grade 1 or less, and resume at a reduced dose or permanently discontinue LORBRENA. If Grade 4 hypertension recurs, permanently discontinue LORBRENA. |
Hyperglycemia [see Warnings and Precautions (5.7)] |
Grade 3 (greater than 250 mg/dL) despite optimal anti-hyperglycemic therapy OR Grade 4 | Withhold LORBRENA until hyperglycemia is adequately controlled, then resume LORBRENA at the next lower dosage. If adequate hyperglycemic control cannot be achieved with optimal medical management, permanently discontinue LORBRENA. |
Other Adverse Reactions |
Grade 1 OR Grade 2 | Continue LORBRENA at same dose or reduced dose. |
Grade 3 OR Grade 4 | Withhold LORBRENA until symptoms resolve to less than or equal to Grade 2 or baseline. Resume LORBRENA at reduced dose. |